InvestorsHub Logo
icon url

chickpea598

04/01/19 12:53 PM

#46454 RE: akhsv777 #46453

The new ATM is better terms than the Cantor ATM. If they do raise it will likely be at higher prices, then data into next year will move shares much higher. I firmly believe Oncosec gets PISCES approved next year. If they do get it take a look at where CPRX is hovering right now after nailing an FDA approval (not Oncology but still they will reap revenues). I would say Oncosec should at the very least be $5 on an approval. Merck buyout will happen at some point, or decent licensing deal. I am very long and still a believer here. Good luck fellow believers!